Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Disease crawled date : 2021 - 06 - 10 save search
Worldwide Blood Gas and Electrolyte Analyzer Industry to 2026 - Rise in the Prevalence of Chronic Diseases is Driving Growth
Published: 2021-06-10 (Crawled : 22:00) - prnewswire.com
ABT | News | $105.9 -3.03% 0.38% 11M
|
Health Technology
|
| O: 0.16%
H: 0.0%
C: -0.38%
disease blood growth
Validation of a Whole Blood and Proteomic Stabilized Blood Assay to Monitor the Engagement and Modulation of CD6 on T cells by Itolizumab as a Clinical Pharmacodynamic Biomarker in Autoimmune Diseases
Published: 2021-06-10 (Crawled : 20:00) - equilliumbio.com
EQ | $1.79 -3.24% 0.0% 93K
|
Health Technology
|
| O: -0.14%
H: 3.09%
C: -1.83%
disease blood t-cell biomarkers
European Vaccines Market 2020-2026 by Type, Disease, Administration, Patient, and Country
Published: 2021-06-10 (Crawled : 19:00) - prnewswire.com
JNJ | News | $144.77 0.22% 0.4% 130K
|
Health Technology
|
| O: -0.01%
H: 0.01%
C: -1.26%
GSK | $39.6 -0.88% -0.05% 8.7K
|
Health Technology
|
| O: 0.05%
H: 0.12%
C: -0.25%
SNY | News | $46.11 0.68% 0.7% 3.5M
|
Health Technology
|
| O: 0.13%
H: 0.11%
C: -0.09%
NVAX | $3.89 -2.51% -2.44% 2.9M
|
Health Technology
|
| O: -0.21%
H: 3.31%
C: 2.53%
AZN | $68.53 0.39% 0.39% 4.3K
|
Health Technology
|
| O: 0.49%
H: 0.03%
C: -0.61%
disease europe vaccine
Adaptive Phage Therapeutics Announces Collaboration with Oyster Point Pharma to Target Ophthalmic Diseases
Published: 2021-06-10 (Crawled : 12:00) - biospace.com/
OYST | $11.17 0.18% -0.27%
|
Health Technology
|
| O: 0.98%
H: 1.02%
C: 0.97%
disease collaboration announces collaboration pharma
Oyster Point Pharma Announces Collaboration with Adaptive Phage Therapeutics (APT) to Target Ophthalmic Diseases
Published: 2021-06-10 (Crawled : 12:00) - biospace.com/
OYST | $11.17 0.18% -0.27%
|
Health Technology
|
| O: 0.98%
H: 1.02%
C: 0.97%
disease collaboration announces collaboration pharma
Sensorion Appoints Gene Therapy and Rare Disease Expert Nora Yang as Chief Scientific Officer
Published: 2021-06-10 (Crawled : 11:00) - biospace.com/
AMGN | $264.07 -0.59% -0.59% 350
|
Health Technology
|
| O: 0.02%
H: 2.4%
C: 2.12%
disease sensor gene therapy therapy gene therapies rare
MannKind and Thirona Bio Join Forces to Evaluate Potential Inhaled Therapy for Fibrotic Lung Diseases
Published: 2021-06-10 (Crawled : 11:00) - globenewswire.com
MNKD | $4.1 1.23% 1.34% 2.5M
|
Health Technology
|
| O: 0.98%
H: 0.73%
C: -2.18%
disease potential therapy
Gainers vs Losers
| 57% | 43% |
Top 10 Gainers
INVO | $1.82 139.47% 49.67% 1.4M
|
Health Technology
WISA 4 | $9.25 51.64% 34.27% 64M
|
Electronic Technology
HOLO | $2.24 -5.49% 27.74% 7.7M
|
SRFM 4 | $0.3859 -12.3% 23.84% 660K
|
n/a
CTM | $0.2201 -2.31% 22.67% 48K
|
n/a
VIAO | $0.262 0.77% 16.03% 14M
|
Electronic Technology
DXF | $0.2708 -5.71% 14.48% 190K
|
Finance
SYTA | $2.9 17.89% 12.77% 300K
|
Non-Energy Minerals
GRFX | $0.2159 -10.04% 12.55% 5.9K
|
n/a
BHIL | $0.1722 -3.8% 12.08% 290K
|
Agriculture, Forestry, Fishing ...
Your saved searches
Save your searches and get alerts when important news are released.